Search for: "Profiles II, Inc."
Results 281 - 300
of 360
Sorted by Relevance
|
Sort by Date
14 Feb 2009, 11:56 am
II. [read post]
8 Jan 2023, 9:01 pm
In order to achieve this, the new rules require, among other things, (i) both the company and dissident to list all nominees on their respective proxy cards2 and (ii) the proxy card to be presented in a clear, neutral manner. [read post]
8 Nov 2009, 12:25 pm
II. [read post]
27 Apr 2010, 5:04 am
[Update II: Making matters worse, the warrant itself was patently overbroad and may have lacked probable cause for many of the items seized. [read post]
21 Dec 2011, 5:15 am
bit.ly/vXNRti (New Legal Review) Delaware’s Default eDiscovery Developments - bit.ly/rYYhpI (Mark Michels) Digital Data on Patients Raises Risk of Breaches - nyti.ms/sI0AA5 (Nicole Perlroth) Discovery of Financial Info Relevant to Punitive Damage Determination Prior to Summary Judgement – bit.ly/uoccKo (Gregory Joseph) Discovery Order Relieves Party of Review of 65 Million E-Documents - bit.ly/skavfT (Mary Pat Gallagher) eDiscovery Confidential: A Look Ahead At 2012 | Business Computing… [read post]
28 Nov 2017, 11:46 am
Argument … II. [read post]
21 Jun 2012, 4:30 am
Because, as io9 profiled extensively, ”For every dollar spent on ads for drugs, over four dollars in retail sales are garnered. [read post]
2 Jul 2018, 3:18 am
Pennsylvania: The Hornberger Case Hornberger v Dave Gutelius Excavating, Inc., 2017 PA Super 395 [Super. [read post]
13 Nov 2014, 9:23 pm
II. [read post]
31 May 2018, 4:26 pm
Background Astellas Pharma U.S. is a pharmaceutical company and the U.S-based subsidiary of Astellas Pharma, Inc. [read post]
25 Apr 2008, 12:33 pm
Goodman, Inc. case. [read post]
6 Dec 2022, 9:44 am
The next part debunks some of the myths that have grown up around the hiQ case during the years of judicial confusion it has caused.] hiQ Labs, Inc. v. [read post]
16 May 2021, 4:25 pm
On May 2, 2021, the Norwegian data protection authority, Datatilsynet, notified Disqus Inc. [read post]
10 Mar 2011, 7:58 am
As one of the vice president at Lundbeck realized (and committed to email), "we can price these almost anywhere we want given the product profiles. [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
31 Jan 2010, 5:56 pm
Domains by Proxy, Inc. 2. [read post]
27 Jul 2008, 3:27 pm
., joined, as to Parts I, II, and III. [read post]
10 Jan 2024, 8:05 pm
The most high-profile case of the bunch is City of Grants Pass, Oregon v. [read post]
14 Jan 2020, 9:07 am
(relisted after the January 10 conference) Arlene’s Flowers, Inc. v. [read post]
17 Oct 2021, 2:17 pm
Merrell Dow Pharms., Inc., 911 F.2d 941, 958 (3d Cir. 1990); cf. [read post]
